Authors
Latest:
The unique role of the retina optometristZhang’s journey as the first retina optometrist in Colorado
Latest:
Case 3: Achieving Rapid Fluid Resolution in nAMD With FaricimabA panelist discusses how a woman aged 77 years with bilateral neovascular age-related macular degeneration (nAMD) demonstrated different responses to treatments between her eyes, showing a superior response to faricimab in her right eye compared with ranibizumab, highlighting how some patients may respond better to specific anti-VEGF agents.
Latest:
COVID-19 pandemic highlights the power of electronic health recordsElectronic health records may be the future of practice management.
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
AMD, AI, and the future of eye imaging: Inside the 2025 International SPECTRALIS SymposiumWith 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and scenery.
Latest:
Subretinal drusenoid deposits: Marker for unrecognized cardiac diseaseNew research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.
Latest:
Emerging insights into ocular immune-related diseases and treatment optionsIn this study, researchers examine immune mechanisms in ocular diseases like uveitis, AMD, DR, and GO, highlighting microglial roles, targeted therapies, and promising advances in immunotherapy.
Latest:
Faricimab improves vision for minority patients with diabetic macular edemaStudy reveals faricimab effectively treats diabetic macular edema in underrepresented minorities, showing significant visual acuity improvements and safety across diverse patient populations.
Latest:
Retina World Congress: Global innovations transforming treatment strategiesInternational retina specialists converge to explore groundbreaking treatments, drug delivery systems, and surgical innovations at the Retina World Congress 2025.
Latest:
High-resolution multimodal imaging is key in dry AMD therapeutic development, future managementIn an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.
Latest:
Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic AtrophyDr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.
Latest:
Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomesNeovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Latest:
Where might AI be heading?A look at the current state of AI in diabetic eye disease and where the future may take us.
Latest:
AAO 2024: Bonnie An Henderson, MD, explores future of medical education in Kelman LectureHenderson’s presentation touches on the shift in medical education from traditional learning to AI and robotics.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
Vitrectomy: Is higher speed always better?Physicians should consider hydrodynamic cavitation when performing this procedure.
Latest:
Poll: Most anticipated emerging therapies in neovascular AMD and DMEA panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?
Latest:
Pearls for maintaining quality, safety in retina clinics amid a pandemicTo maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimize clinic visits and maximize the use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximizing safety and patients’ vision outcomes.
Latest:
Case 2: Management of Progressive Geographic Atrophy in an 84-Year-Old ManFerhina S. Ali, MD, MPH, discusses the management of progressive geographic atrophy in an 84-year-old man, focusing on the significance of patient education in optimizing treatment outcomes and adherence.
Latest:
Anonymous $40 million gift received by University of Colorado Anschutz Medical Campus Ophthalmology DepartmentThe gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision care.
Latest:
Setting a New Standard in Automated Tracked PerimetryInnovative new features build on the benefits of the iCare COMPASS Automated Perimeter
Latest:
OSN New York Retina 2024: Understanding how next-generation anti-VEGFs perform in real-world settings compared to trialsFerhina S. Ali, MD, discussed the real-world efficacy and durability of next-generation anti-VEGF agents like faricimab and aflibercept 8 mg, emphasizing how large-scale data offers insights into their performance and safety beyond clinical trials.
Latest:
A case of a 79-year-old pseudophakic patient with AMD and rapidly progressing GAThe final case is presented by Dr Adam, showcasing a 79-year old patient with multiple diagnoses and rapid progression of geographic atrophy.
Latest:
When the world went virtual: How ophthalmology’s conferences stayed on trackFive years after the COVID-19 pandemic shutdown reshaped how the world gathers, here's how some of ophthalmology’s leading associations are still applying lessons forged in crisis.
Latest:
Ophthalmologist shares his story on Holocaust Remembrance DayJohn H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his story.
Latest:
Searching for durable therapies for diabetic macular edema amid the pandemicPatients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.
